Connect with us

Health

Generics makers appeal to fix tax on treatment

SHARE:

Published

2 months ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Medicines for Europe to appeal the decision on its challenge to Urban Wastewater Treatment Directive. Medicines for Europe, which represents the generic and biosimilar industry, is fighting tooth and nail to address what it considers disproportionate costs that will be imposed on the pharma sector by the current extended producer responsibility (EPR) scheme embedded in the Urban Wastewater Treatment Directive (UWWTD).

Yesterday, Medicines for Europe announced its decision to challenge the Court of First Instance's decision that it lacked legal standing to challenge the UWWTD. The technical decision meant that the Court did not address the substance of their arguments.

The Directive, which was adopted with little fanfare in 2024, has attracted growing controversy. Pharmaceuticals are one of the sectors - along with cosmetics - which have been identified in the legislation for an extended producer responsibility levy. ‘Extended producer responsibility’ will...

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending